Solid Biosciences (SLDB) EPS (Weighted Average and Diluted): 2020-2024
Historic EPS (Weighted Average and Diluted) for Solid Biosciences (SLDB) over the last 3 years, with Dec 2024 value amounting to -$1.02.
- Solid Biosciences' EPS (Weighted Average and Diluted) fell 2.00% to -$1.02 in Q4 2024 from the same period last year, while for Dec 2024 it was -$3.06, marking a year-over-year increase of 36.78%. This contributed to the annual value of -$3.06 for FY2024, which is 36.65% up from last year.
- Latest data reveals that Solid Biosciences reported EPS (Weighted Average and Diluted) of -$1.02 as of Q4 2024, which was down 29.11% from -$0.79 recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' EPS (Weighted Average and Diluted) peaked at -$0.61 during Q2 2024, and registered a low of -$6.17 during Q4 2020.
- Over the past 3 years, Solid Biosciences' median EPS (Weighted Average and Diluted) value was -$1.02 (recorded in 2024), while the average stood at -$1.33.
- Over the last 5 years, Solid Biosciences' EPS (Weighted Average and Diluted) had its largest YoY gain of 63.02% in 2023, and its largest YoY loss of 47.06% in 2023.
- Over the past 4 years, Solid Biosciences' EPS (Weighted Average and Diluted) (Quarterly) stood at -$6.17 in 2020, then reached -$0.68 in 2022, then crashed by 47.06% to -$1 in 2023, then dropped by 2.00% to -$1.02 in 2024.
- Its last three reported values are -$1.02 in Q4 2024, -$0.79 for Q3 2024, and -$0.61 during Q2 2024.